A carregar...
Proteasome Inhibitor Bortezomib Suppresses Nuclear Factor-Kappa B Activation and Ameliorates Eye Inflammation in Experimental Autoimmune Uveitis
Bortezomib is a proteasome inhibitor used for hematologic cancer treatment. Since it can suppress NF-κB activation, which is critical for the inflammatory process, bortezomib has been found to possess anti-inflammatory activity. In this study, we evaluated the effect of bortezomib on experimental au...
Na minha lista:
Publicado no: | Mediators Inflamm |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Hindawi Publishing Corporation
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4306382/ https://ncbi.nlm.nih.gov/pubmed/25653480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/847373 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|